The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial
Victor Legrand1, MD; Thomas Cuisset², MD; Patrick Chenu³, MD; Mathy Vrolix4, MD; Christophe Martinez1, MD; Joseph Dens4, MD; Olivier Gach1, MD; Jean Boland5, MD; Marc J. Claeys6, MD; Julien Magne1, PhD; Emanuele Barbato², MD; William Wijns²*, MD
1. CHU de Liège, Liège, Belgium; 2. Cardiovascular Center Aalst OLV-Clinic, Aalst, Belgium; 3. CHU Mont Godinne, Godinne, Belgium; 4. St Jan Ziekenhuis Genk, Genk, Belgium; 5. CHR Citadelle Liège, Liège, Belgium; 6. UZ Antwerpen, Antwerp, Belgium
Aims: The Stent Thrombosis In Belgium (STIB) trial aimed to determine whether assessing platelet reactivity (PR) in patients with stable coronary artery disease undergoing elective percut